ARSD 20:06:53:43. Review of information by independent review organization for experimental or investigational treatment reviews

Each clinical reviewer selected pursuant to §§ 20:06:53:39 to 20:06:53:41, inclusive, shall review all of the information and documents received pursuant to § 20:06:53:42 and any other information submitted in writing by the covered person or the covered person's authorized representative pursuant to § 20:06:53:39. Upon receipt of any information submitted by the covered person or the covered person's authorized representative pursuant to § 20:06:53:39, within one business day after the receipt of the information, the assigned independent review organization shall forward the information to the health carrier.